128 related articles for article (PubMed ID: 38211830)
1. Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
Moore-Vasram S; Sawhney M; Houlden RL; Groome PA; Goldie C; Li W; Hay AE; Tranmer J
Can J Diabetes; 2024 Apr; 48(3):195-203.e1. PubMed ID: 38211830
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies.
Healy SJ; Nagaraja HN; Alwan D; Dungan KM
Endocrine; 2017 Apr; 56(1):90-97. PubMed ID: 28058528
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.
Rowbottom L; Stinson J; McDonald R; Emmenegger U; Cheng S; Lowe J; Giotis A; Cheon P; Chow R; Pasetka M; Thavarajah N; Pulenzas N; Chow E; DeAngelis C
Ann Palliat Med; 2015 Apr; 4(2):70-7. PubMed ID: 25971294
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
5. Association between diabetes and haematological malignancies: a population-based study.
Gong IY; Cheung MC; Read S; Na Y; Lega IC; Lipscombe LL
Diabetologia; 2021 Mar; 64(3):540-551. PubMed ID: 33409570
[TBL] [Abstract][Full Text] [Related]
6. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
7. Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort study.
Lee EK; Koo B; Hwangbo Y; Lee YJ; Baek JY; Cha YJ; Kim SY; Sim SH; Lee KS; Park IH; Lee H; Joo J; Go S; Heo SC; Moon MK
Diabetes Res Clin Pract; 2021 Apr; 174():108751. PubMed ID: 33722701
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity.
Brunello A; Kapoor R; Extermann M
Am J Clin Oncol; 2011 Jun; 34(3):292-6. PubMed ID: 20622641
[TBL] [Abstract][Full Text] [Related]
9. Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.
Wintergerst KA; Foster MB; Sullivan JE; Woods CR
J Diabetes Sci Technol; 2012 Jan; 6(1):5-14. PubMed ID: 22401317
[TBL] [Abstract][Full Text] [Related]
10. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
11. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.
Chiu BC; Gapstur SM; Greenland P; Wang R; Dyer A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2348-54. PubMed ID: 17164355
[TBL] [Abstract][Full Text] [Related]
12. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
Zylla D; Gilmore G; Eklund J; Richter S; Carlson A
J Diabetes Complications; 2019 Apr; 33(4):335-339. PubMed ID: 30717892
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.
Lamar ZS; Dothard A; Kennedy L; Isom S; Robinson M; Vaidya R; Hurd D; McClain D; Lesser G
Leuk Lymphoma; 2018 Aug; 59(8):1871-1877. PubMed ID: 29252084
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid induced diabetes and lipid profiles disorders amongst lymphoid malignancy survivors.
Dehghani M; Hobbi AM; Haghighat S; Fariba Karimi ; Ramzi M; Vojdani R; Karimi M
Diabetes Metab Syndr; 2020; 14(6):1645-1649. PubMed ID: 32898741
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced hyperglycemia.
Kwon S; Hermayer KL; Hermayer K
Am J Med Sci; 2013 Apr; 345(4):274-277. PubMed ID: 23531958
[TBL] [Abstract][Full Text] [Related]
16. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
17. The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis.
Zohar Y; Zilberman Itskovich S; Koren S; Zaidenstein R; Marchaim D; Koren R
Intern Emerg Med; 2021 Apr; 16(3):719-728. PubMed ID: 32964373
[TBL] [Abstract][Full Text] [Related]
18. Critical illness in patients with hematologic malignancy: a population-based cohort study.
Ferreyro BL; Scales DC; Wunsch H; Cheung MC; Gupta V; Saskin R; Thyagu S; Munshi L
Intensive Care Med; 2021 Oct; 47(10):1104-1114. PubMed ID: 34519845
[TBL] [Abstract][Full Text] [Related]
19. One- and five-year risk of death and cardiovascular complications for hospitalized patients with hyperglycemia without diagnosed diabetes: An observational study.
Tuna M; Manuel DG; Bennett C; Lawrence N; van Walraven C; Keely E; Malcolm J; D Reid R; Forster AJ
J Hosp Med; 2014 Jun; 9(6):365-71. PubMed ID: 24610578
[TBL] [Abstract][Full Text] [Related]
20. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
